How do I order an azathioprine (thiopurine metabolite) level test?

How to Order Azathioprine (Thiopurine Metabolite) Levels

Order thiopurine metabolite testing by requesting measurement of 6-thioguanine nucleotides (6-TGN) and 6-methylmercaptopurine (6-MMP) in red blood cells, typically sent to a reference laboratory with LC-MS/MS or HPLC capability.

When to Order Metabolite Testing

The most recent guidelines 1 and consensus statements 2 recommend checking thiopurine metabolites in specific clinical scenarios:

Reactive (Problem-Driven) Testing

• Suboptimal response or loss of response to azathioprine therapy
• Elevated liver enzymes (ALT/AST) while on treatment
• Cytopenia (low blood counts) developing during therapy
• Suspected non-adherence to medication
• Before considering switching to alternative immunosuppression

Proactive Testing

While reactive testing is more established, emerging evidence 3 suggests proactive monitoring may identify dosing issues earlier and improve long-term remission rates.

What the Lab Actually Measures

The test measures two key metabolites 2, 4:

1. 6-TGN (6-thioguanine nucleotides) - the active therapeutic metabolite
2. 6-MMP (6-methylmercaptopurine) - an inactive metabolite associated with hepatotoxicity

Important technical note: Most routine HPLC methods measure hydrolysis products rather than the metabolites directly, detecting approximately 69% of actual TGN levels (primarily TGTP and TGDP) 5. However, this doesn't affect clinical interpretation when using established reference ranges.

Practical Ordering Details

Test Name Variations

• "Thiopurine metabolites"
• "Azathioprine metabolites"
• "6-TGN and 6-MMP levels"
• "Thioguanine nucleotides"

Sample Requirements

• Specimen: Whole blood in EDTA (purple top) tube
• Timing: Can be drawn at any time (not time-dependent like trough levels)
• Volume: Typically 3-5 mL
• Processing: Send to reference laboratory; most hospital labs send out

Critical Caveat

Do not order metabolite levels within 3 months of blood transfusion - results will be inaccurate due to donor red blood cells 6, 4.

Interpreting Results

Therapeutic Ranges (Most Common Method - Lennard)

For IBD and most conditions 6, 2, 7:

• 6-TGN therapeutic range: 230-450 pmol/8×10⁸ RBC
• 6-MMP upper limit: <5,700 pmol/8×10⁸ RBC

For Autoimmune Hepatitis 1, 8:

• 6-TGN therapeutic range: 223-450 pmol/0.2 mL (equivalent units)
• 6-MMP upper limit: <5,700 pmol/0.2 mL

Note: Some labs use the Dervieux/Boulieu method with higher cutoffs (6-TGN 600-1200 pmol/8×10⁸ RBC) 6. Verify your lab's reference range.

Clinical Decision Algorithm Based on Results

Low 6-TGN (<230) + Low 6-MMP:

• Indicates non-adherence or under-dosing
• Action: Check adherence first, then increase azathioprine dose 1, 2

Low 6-TGN (<230) + High 6-MMP (≥5,700):

• Indicates "shunter" or hypermethylator - preferentially metabolizes to inactive 6-MMP
• High risk of hepatotoxicity with dose escalation
• Action: Add allopurinol 100 mg daily AND reduce azathioprine to 25-33% of current dose 6, 1, 2

Therapeutic 6-TGN (230-450) + Normal/High 6-MMP:

• Adequate metabolite levels but inadequate response
• Action: Consider switching drug class - therapy failure 6, 1

High 6-TGN (>450) + Normal 6-MMP:

• Risk of myelosuppression
• Suggests low TPMT activity (heterozygote)
• Action: Reduce dose by 50% and monitor CBC closely 6, 2

High 6-TGN + High 6-MMP:

• Overdosing
• Action: Reduce dose; if clinically resistant despite high levels, change drug category 6

Integration with Routine Monitoring

Metabolite testing does not replace routine CBC and liver function monitoring 2, 9, 4:

• Weeks 1-4: CBC and LFTs weekly
• Weeks 4-12: CBC and LFTs every 2 weeks
• After 12 weeks: CBC and LFTs every 3 months minimum
• After dose changes: Return to weekly monitoring for 2-4 weeks

Common Pitfalls to Avoid

1. Don't order metabolites as first-line monitoring - they supplement, not replace, CBC/LFT monitoring
2. Don't interpret low levels as treatment failure without first assessing adherence
3. Don't increase azathioprine dose in shunters (high 6-MMP) - this worsens hepatotoxicity; use allopurinol co-therapy instead
4. Don't forget to reduce azathioprine dose dramatically (to 25-33%) when adding allopurinol 6, 2
5. Don't order within 3 months of transfusion - results will be meaningless

Special Populations

Patients on allopurinol co-therapy: Metabolite monitoring is essential to guide the reduced azathioprine dosing and confirm therapeutic 6-TGN levels are achieved 1, 8.

Combination therapy with anti-TNF agents: Optimal 6-TGN targets may be lower than monotherapy, though this remains uncertain 7.